Literature DB >> 24123007

Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine.

Ho Wing Chan1, Narendra P Singh, Henry C Lai.   

Abstract

Derivatives of artemisinin, a compound extracted from the wormwood Artemisia annua L, have potent anticancer properties. The anticancer mechanisms of artemisinin derivatives have not been fully-elucidated. We hypothesize that the cytotoxicity of these compounds is due to the free radicals formed by interaction of their endoperoxide moiety with intracellular iron in cancer cells. The effects of N-tert-butyl-alpha-phenylnitrone (PBN), a spin-trap free radical scavenger, and deferoxamine (DX), an iron chelating agent, on the in vitro cytotoxicity of dihyroartemisinin (DHA) toward Molt-4 human T-lymphoblastoid leukemia cells were investigated in the present study. Dihydroartemisinin effectively killed Molt-4 cells in vitro. Its cytotoxicity was significantly attenuated by PBN and DX. Based on the data of our present and previous studies, we conclude that one anticancer mechanism of dihydroartemisinin is the formation of toxic-free radicals via an iron-mediated process.

Entities:  

Keywords:  Dihydroartemisinin; Molt-4 cells; N-tert-butyl-alpha-phenylnitrone; deferoxamine; free radical; iron

Mesh:

Substances:

Year:  2013        PMID: 24123007

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.

Authors:  Jia-Tian Cao; Hui-Min Mo; Yue Wang; Kai Zhao; Tian-Tian Zhang; Chang-Qian Wang; Kai-Lin Xu; Zhi-Hua Han
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis.

Authors:  Bing Yuan; Feng Liao; Zhi-Zhou Shi; Yuan Ren; Xiao-Li Deng; Ting-Ting Yang; Deng-Yuan Li; Ru-Fang Li; Dan-Dan Pu; Yu-Jue Wang; Yan Tan; Zhen Yang; Yun-Hui Zhang
Journal:  Onco Targets Ther       Date:  2020-10-27       Impact factor: 4.147

Review 3.  Artemisinin-type drugs for the treatment of hematological malignancies.

Authors:  R I Mancuso; M A Foglio; S T Olalla Saad
Journal:  Cancer Chemother Pharmacol       Date:  2020-11-03       Impact factor: 3.333

4.  Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety.

Authors:  Xuan Zhao; Hang Zhong; Rui Wang; Dan Liu; Samuel Waxman; Linxiang Zhao; Yongkui Jing
Journal:  Oncotarget       Date:  2015-03-20

Review 5.  Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate.

Authors:  Mark Frederick McCarty; Francisco Contreras
Journal:  Front Oncol       Date:  2014-09-16       Impact factor: 6.244

6.  Antioxidant Properties of Artemisia annua Extracts in Model Food Emulsions.

Authors:  Monika Skowyra; Maria Gabriela Gallego; Francisco Segovia; Maria Pilar Almajano
Journal:  Antioxidants (Basel)       Date:  2014-03-03

Review 7.  Emerging Mechanisms and Disease Implications of Ferroptosis: Potential Applications of Natural Products.

Authors:  Chun Ge; Sujie Zhang; Huiwen Mu; Shaojun Zheng; Zhaoyi Tan; Xintong Huang; Chen Xu; Jianjun Zou; Yubing Zhu; Dong Feng; Jiye Aa
Journal:  Front Cell Dev Biol       Date:  2022-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.